These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6846733)

  • 1. Serial changes of cranial computerized tomographic findings in Wilson disease during D-penicillamine therapy.
    Mizutani N; Maehara M; Negoro T; Watanabe K
    Brain Dev; 1983; 5(1):48-52. PubMed ID: 6846733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computerized cranial tomography in Wilson disease: report of a case before and after penicillamine therapy.
    Lanzi G; Balottin U; Cecchini A; Ottolini A
    Ital J Neurol Sci; 1981 Dec; 2(4):383-6. PubMed ID: 7333829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents.
    Williams FJ; Walshe JM
    Brain; 1981 Dec; 104(Pt 4):735-52. PubMed ID: 7326565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography in Wilson disease.
    Harik SI; Post MJ
    Neurology; 1981 Jan; 31(1):107-10. PubMed ID: 7192819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized cranial tomography in Wilson disease.
    Nelson RF; Guzman DA; Grahovac Z; Howse DC
    Neurology; 1979 Jun; 29(6):866-8. PubMed ID: 572009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Computer tomographic studies in Wilson disease].
    Nix WA; Ludwig G; Backmund H
    Nervenarzt; 1984 Oct; 55(10):544-8. PubMed ID: 6504223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ophthalmologic manifestations of Wilson's disease.
    Wiebers DO; Hollenhorst RW; Goldstein NP
    Mayo Clin Proc; 1977 Jul; 52(7):409-16. PubMed ID: 875462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short interval change of 99mTc-ethyl cysteinate dimer single photon emission computed tomography in Wilson's disease].
    Imai N; Nozaki H; Miyata K; Terayama Y; Ishihara N
    No To Shinkei; 1999 Sep; 51(9):785-9. PubMed ID: 10511956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroradiological findings in 2 cases of Wilson disease with neurological involvement].
    Troncoso M; Badilla L; Bravo E; Miranda M; Gajewski C; Barrios A; Villagra R
    Rev Med Chil; 1998 Jan; 126(1):81-7. PubMed ID: 9629758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatolenticular degeneration. Clinical course in 2 siblings during penicillamine therapy].
    Højer-Pedersen E
    Ugeskr Laeger; 1979 Sep; 141(38):2610-1. PubMed ID: 483457
    [No Abstract]   [Full Text] [Related]  

  • 11. [Regression of a Kayser-Fleischer ring in a case of Wilson's disease during penicillamine therapy (author's transl)].
    Hiti H; Harpf H; Wutz W; Schmut O
    Klin Monbl Augenheilkd; 1980 Feb; 176(2):235-8. PubMed ID: 7420971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences with penicillamine in Wilson's disease].
    Lössner J; Bachmann H; Eichner B
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():48-53. PubMed ID: 829635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disappearance of Kayser-Fleischer rings. Effects of penicillamine.
    Sussman W; Scheinberg IH
    Arch Ophthalmol; 1969 Dec; 82(6):738-41. PubMed ID: 5355260
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of D-penicillamine treatment on brain metabolism in Wilson's disease: a case study.
    De Volder A; Sindic CJ; Goffinet AM
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):947-9. PubMed ID: 3264567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatolenticular degeneration: critical evaluation of the diagnostic criteria in 95 cases].
    Barbosa ER; Scaff M; Comerlatti LR; Canelas HM
    Arq Neuropsiquiatr; 1985 Sep; 43(3):234-42. PubMed ID: 4091735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Wilson's disease with primary CNS manifestation--current status in diagnosis and therapy].
    Willeit J; Kiechl SG; Birbamer G; Schmidauer C; Felber S; Aichner F; Saltvari L; Metzler R; Judmaier G
    Fortschr Neurol Psychiatr; 1992 Jun; 60(6):237-45. PubMed ID: 1644402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worsening of Wilson disease following penicillamine therapy.
    Kalita J; Kumar V; Chandra S; Kumar B; Misra UK
    Eur Neurol; 2014; 71(3-4):126-31. PubMed ID: 24356057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some therapeutic observations in Wilson's disease.
    Shoulson I; Goldblatt D; Plassche W; Wilson G
    Adv Neurol; 1983; 37():239-46. PubMed ID: 6858775
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
    Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computerized cranial tomography in presymptomatic and hepatic form of Wilson's disease.
    Dettori P; Rachele MG; Demelia L; Pelaghi AE; Nurchi AM; Aromando P; Giagheddu M
    Eur Neurol; 1984; 23(1):56-63. PubMed ID: 6714278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.